These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31648846)

  • 21. Mediterranean spotted fever in a patient with Crohn's disease under adalimumab: First case report and review of the literature.
    Santos-Antunes J; Nunes AC; Macedo G
    Gastroenterol Hepatol; 2015; 38(6):379-80. PubMed ID: 25073681
    [No Abstract]   [Full Text] [Related]  

  • 22. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
    Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I
    Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400
    [No Abstract]   [Full Text] [Related]  

  • 23. Crohn's Disease in which the Patient Developed Aortitis during Treatment with Adalimumab.
    Kiyohara H; Hisamatsu T; Matsuoka K; Naganuma M; Kameda H; Seta N; Takeuchi T; Kanai T
    Intern Med; 2015; 54(14):1725-32. PubMed ID: 26179525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic meningococcemia].
    Carré D; Dompmartin A; Sannier K; Verneuil L; Bravard P; Leroy D
    Ann Dermatol Venereol; 2005 Apr; 132(4):355-8. PubMed ID: 15886564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgA nephropathy onset in a Crohn's disease patient treated with Adalimumab.
    Bruzzese V; Lorenzetti R; Rosa M; Di Giulio S; Hassan C; Costas G; Zullo A
    Minerva Gastroenterol Dietol; 2016 Jun; 62(2):223-4. PubMed ID: 27091038
    [No Abstract]   [Full Text] [Related]  

  • 26. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab.
    Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ
    Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973
    [No Abstract]   [Full Text] [Related]  

  • 27. Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.
    Cheemalavagu S; McCoy SS; Knight JS
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32041760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic adalimumab induces peripheral corneal infiltrates: a case report.
    Matet A; Daruich A; Beydoun T; Cosnes J; Bourges JL
    BMC Ophthalmol; 2015 Jun; 15():57. PubMed ID: 26044064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adalimumab-induced lichenoid drug eruption.
    El Habr C; Meguerian Z; Sammour R
    J Med Liban; 2014; 62(4):238-40. PubMed ID: 25807724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.
    Van Steenbergen S; Bian S; Vermeire S; Van Assche G; Gils A; Ferrante M
    Aliment Pharmacol Ther; 2017 Apr; 45(7):923-932. PubMed ID: 28164321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic meningococcal disease.
    Jennens ID; O'Reilley M; Yung AP
    Med J Aust; 1990 Nov; 153(9):556-9. PubMed ID: 2122194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary meningococcal arthritis in a prosthetic knee joint.
    Vikram HR; Buencamino RB; Aronin SI
    J Infect; 2001 May; 42(4):279-81. PubMed ID: 11545573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease.
    Ogata H; Watanabe M; Matsui T; Hase H; Okayasu M; Tsuchiya T; Shinmura Y; Hibi T
    J Crohns Colitis; 2016 Sep; 10(9):1033-41. PubMed ID: 26961546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Painful knees and hearing-loss: a rare presentation of meningococcal disease.
    Kahlmann V; Alves C; Koeleman J; Korswagen LA
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27358094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAFETY PROFILE OF ANTI-TNF THERAPY IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN SINGLE-CENTER DIRECT RETROSPECTIVE COMPARISON BETWEEN INFLIXIMAB AND ADALIMUMAB.
    Bau M; Zacharias P; Ribeiro DA; Boaron L; Steckert Filho A; Kotze PG
    Arq Gastroenterol; 2017 Dec; 54(4):328-332. PubMed ID: 28954043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-TNF alpha-induced eruptive nevi: Three cases].
    Mazaud C; Breban M; Mahé E
    Ann Dermatol Venereol; 2019 Oct; 146(10):640-645. PubMed ID: 31146896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
    Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
    J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paediatric meningococcaemia in northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination.
    Eton V; Tsang RS; Ulanova M
    JMM Case Rep; 2016 Feb; 3(1):e005017. PubMed ID: 28348748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different clinical manifestations of meningococcaemia: three patient reports.
    Leeman J; Pierard D; Huyghens L
    Eur J Emerg Med; 1996 Sep; 3(3):179-82. PubMed ID: 9023497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease.
    Kump PK; Högenauer C; Wenzl HH; Petritsch W
    J Crohns Colitis; 2013 Feb; 7(1):e15-8. PubMed ID: 22770648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.